TOKYO — A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients following the deaths of 20 people who took it. Kissei Pharmaceutical, ...
The recommendation in Europe follows a similar move by the FDA earlier this year.
The FDA wants to withdraw approval of Amgen’s drug after years on the market. The company is defending it.
The last person to have come into contact with someone confirmed to have the Andes variant of hantavirus completed their six-week quarantine on Thursday, tested negative and returned home, triggering ...
June 26 (Reuters) - The European Medicines Agency on Friday recommended revoking the marketing authorisation for Amgen's rare autoimmune disease drug, Tavneos, citing a lack of benefits that outweigh ...
June 26 (Reuters) - Europe's drug regulator on Friday recommended revoking the marketing authorization for Amgen's rare autoimmune disease medicine, citing concerns over the integrity of its trial ...
Add Yahoo as a preferred source to see more of our stories on Google. The Amgen logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration June 29 (Reuters) - The New ...
Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...
A new kind of antibody drug that more efficiently enters the brain could slow the progression of Alzheimer's disease with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results